AbFero Pharmaceuticals has a total of 14 patents globally, out of which 3 have been granted. Of these 14 patents, more than 85% patents are active. Parallelly, United States of America and Hong Kong seems to be the main focused R&D center and also United Kingdom is the origin country of AbFero Pharmaceuticals.
AbFero Pharmaceuticals was founded in the year 2016. Clinical-stage pharmaceutical company Abfero Pharmaceuticals focuses on the medical and healthcare sectors. Their goal is to create the safest, most effective, and best-in-class oral iron chelators possible to treat iron overload disorders.
Do read about some of the most popular patents of AbFero Pharmaceuticals which have been covered by us in this article and also you can find AbFero Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over AbFero Pharmaceuticals patent portfolio.
How many patents does AbFero Pharmaceuticals have?
AbFero Pharmaceuticals has a total of 14 patents globally. These patents belong to 2 unique patent families. Out of 14 patents, 12 patents are active.
How Many Patents did AbFero Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | AbFero Pharmaceuticals Applications Filed | AbFero Pharmaceuticals Patents Granted |
| 2023 | 1 | 1 |
| 2022 | 1 | 2 |
| 2020 | 1 | – |
| 2019 | 1 | – |
| 2017 | 10 | – |
How many AbFero Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did AbFero Pharmaceuticals File in Different Countries?
Countries in which AbFero Pharmaceuticals Filed Patents
| Country | Patent |
| United States Of America | 2 |
| Korea (South) | 2 |
| Japan | 2 |
| Australia | 2 |
| Singapore | 1 |
| Europe | 1 |
| Canada | 1 |
| China | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centers of AbFero Pharmaceuticals Patents Located?
What Percentage of AbFero Pharmaceuticals US Patent Applications were Granted?
AbFero Pharmaceuticals (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of AbFero Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for AbFero Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Biospark Intellectual Property Law | 1 | 0.0% |
List of AbFero Pharmaceuticals patents
| AbFero Pharmaceuticals Patents | Title |
| US20210322301A1 | Dosing Regimens For Treating Metal-Mediated Conditions |
| EP3493801A4 | Dosing Regimens For Treating Metal-Mediated Conditions |
| CN109862892A | Dosing Regimens For Treating Metal-Mediated Conditions |
| CA3032837A1 | Dosing Regimens For Treating Metal-Mediated Conditions |
| AU2017307566B2 | Dosing Regimens For Treating Metal-Mediated Conditions |
| AU2023229497A1 | Dosing Regimens For Treating Metal-Mediated Conditions |
| JP7125396B2 | Dosing Regimens For Treating Metal-Induced Diseases |
| JP2022163170A | Dosing Regimen For Treating Metal-Induced Diseases |
| HK40009939A | Dosing Regimens For Treating Metal-Mediated Conditions |
| KR102480882B1 | Dosage Regimens For Treating Metal-Mediated Conditions |
| KR1020230004944A | Dosing Regimens For Treating Metal-Mediated Conditions |
| SG11201900978RA | Dosing Regimens For Treating Metal-Mediated Conditions |
| US20180036228A1 | Dosing Regimens For Treating Metal-Mediated Conditions |
| WO2018027132A1 | Dosing Regimens For Treating Metal-Mediated Conditions |
What are AbFero Pharmaceuticals key innovation segments?
What Technologies are Covered by AbFero Pharmaceuticals?
The chart below distributes patents filed by AbFero Pharmaceuticals